These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
211 related articles for article (PubMed ID: 10961355)
21. Plasma beta-endorphin levels and glucose tolerance in patients with chronic renal failure. Barreca T; Robaudo C; Cataldi A; Garibaldi A; Cianciosi P; Russo R; Rolandi E; Franceschini R Biomed Pharmacother; 1995; 49(6):283-7. PubMed ID: 7579009 [TBL] [Abstract][Full Text] [Related]
22. Glucose intolerance in uremic patients: the relative contributions of impaired beta-cell function and insulin resistance. Alvestrand A; Mujagic M; Wajngot A; Efendic S Clin Nephrol; 1989 Apr; 31(4):175-83. PubMed ID: 2565775 [TBL] [Abstract][Full Text] [Related]
23. [Value of continuous glucose monitoring in screening for diabetes in cystic fibrosis]. Khammar A; Stremler N; Dubus JC; Gross G; Sarles J; Reynaud R Arch Pediatr; 2009 Dec; 16(12):1540-6. PubMed ID: 19854630 [TBL] [Abstract][Full Text] [Related]
24. Tolbutamide causes a modest increase in insulin secretion in cystic fibrosis patients with impaired glucose tolerance. Hinds A; Sheehan AG; Parsons HG Metabolism; 1995 Jan; 44(1):13-8. PubMed ID: 7854158 [TBL] [Abstract][Full Text] [Related]
25. Glucagon suppression during OGTT worsens while suppression during IVGTT sustains alongside development of glucose intolerance in patients with chronic pancreatitis. Knop FK; Vilsbøll T; Larsen S; Madsbad S; Holst JJ; Krarup T Regul Pept; 2010 Sep; 164(2-3):144-50. PubMed ID: 20573586 [TBL] [Abstract][Full Text] [Related]
26. Insulin responses to intravenous glucose, intravenous arginine and a hyperglycaemic clamp in ICA-positive subjects with different degrees of glucose tolerance. Rakotoambinina B; Timsit J; Deschamps I; Laborde K; Gautier D; Jos J; Boitard C; Robert JJ Diabetes Metab; 1997 Feb; 23(1):43-50. PubMed ID: 9059765 [TBL] [Abstract][Full Text] [Related]
27. Comparison of glucose tolerance tests to detect the insulin sensitizing effects of a bout of continuous exercise. Ortega JF; Hamouti N; Fernández-Elías VE; Mora-Rodriguez R Appl Physiol Nutr Metab; 2014 Jul; 39(7):787-92. PubMed ID: 24971679 [TBL] [Abstract][Full Text] [Related]
28. [Relation between intravenous glucose tolerance tests and oral glucose tolerance tests in severely obese patients. II]. Klinger R; Klinger M; Lattuada E; Micheletto G; Vita PM Minerva Med; 1983 Oct; 74(41):2447-52. PubMed ID: 6358953 [TBL] [Abstract][Full Text] [Related]
29. Study of A- and B-cell function in beta-thalassemia major. Maioli M; Pacifico A; Frulio T; Longinotti M Acta Diabetol Lat; 1983; 20(2):143-52. PubMed ID: 6349202 [TBL] [Abstract][Full Text] [Related]
30. Beta cell function in participants with single or multiple islet autoantibodies at baseline in the TEDDY Family Prevention Study: TEFA. Martinez MM; Salami F; Larsson HE; Toppari J; Lernmark Å; Kero J; Veijola R; Koskenniemi JJ; Tossavainen P; Lundgren M; Borg H; Katsarou A; Maziarz M; Törn C; Endocrinol Diabetes Metab; 2021 Apr; 4(2):e00198. PubMed ID: 33855205 [TBL] [Abstract][Full Text] [Related]
31. [Disturbance of glucose metabolism in dialysis patients--analysis of three studies of ivGTT in dialysis patients during 25 years]. Kaneda H; Sano K; Nagatsuka C; Shitomi K; Murata T Nihon Rinsho; 1992 Jan; 50 Suppl():521-6. PubMed ID: 1578733 [No Abstract] [Full Text] [Related]
33. Glucose-induced insulin secretion in uremia: effects of aminophylline infusion and glucose loads. Allegra V; Mengozzi G; Martimbianco L; Vasile A Kidney Int; 1990 Dec; 38(6):1146-50. PubMed ID: 1963648 [TBL] [Abstract][Full Text] [Related]
34. Establishment of a Refined Oral Glucose Tolerance Test in Pigs, and Assessment of Insulin, Glucagon and Glucagon-Like Peptide-1 Responses. Manell E; Hedenqvist P; Svensson A; Jensen-Waern M PLoS One; 2016; 11(2):e0148896. PubMed ID: 26859145 [TBL] [Abstract][Full Text] [Related]
35. Loss of early phase of insulin release in humans impairs glucose tolerance and blunts thermic effect of glucose. Calles-Escandon J; Robbins DC Diabetes; 1987 Oct; 36(10):1167-72. PubMed ID: 2888695 [TBL] [Abstract][Full Text] [Related]
36. Insulin response to intravenous glucose in patients with anorexia nervosa showing low insulin response to oral glucose. Nozaki T; Tamai H; Matsubayashi S; Komaki G; Kobayashi N; Nakagawa T J Clin Endocrinol Metab; 1994 Jul; 79(1):217-22. PubMed ID: 8027230 [TBL] [Abstract][Full Text] [Related]
37. Clinical use of the glucose disappearance rate. SAUCIER G; NADEAU G; BRUNET J; MOISAN A Can Med Assoc J; 1963 Jun; 88(25):1231-7. PubMed ID: 13986795 [TBL] [Abstract][Full Text] [Related]
39. A COMPARISON OF THE ORAL AND INTRAVENOUS GLUCOSE TOLERANCE TESTS IN NON-DIABETIC, POSSIBLE DIABETIC AND DIABETIC SUBJECTS. NADON GW; LITTLE JA; HALL WE; O'SULLIVAN MO Can Med Assoc J; 1964 Dec; 91(26):1350-3. PubMed ID: 14228226 [TBL] [Abstract][Full Text] [Related]